Trial Profile
Phase Ib trial of indolepropionic acid in elderly volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2010
Price :
$35
*
At a glance
- Drugs Indolepropionic acid (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 30 Dec 2010 Pharmacokinetic outcomes were reported in an Intellect Neurosciences media release.
- 27 Oct 2010 Initial results reported in an Intellect Neurosciences media release. A final audited report of trial data is anticipated in Dec 2010.
- 19 Aug 2010 New trial record